Dr. Agénor investigates the structural and social determinants of sexual and reproductive health and cancer screening and prevention among marginalized U.S. populations—especially sexual minority cisgender women and girls, transgender and gender diverse young adults, and lesbian, gay, bisexual, transgender, and queer (LGBTQ+) people of color—using an intersectional lens and mixed-methods research approach.
In the News
Uses multivariable logistic regression to examine the associations between sexual behavior and sexual identity (modeled separately) and sexually transmitted infections testing in the past year, Pap test use in the last three years, lifetime HIV testing, and lifetime human papillomavirus (HPV) testing.
Examines whether cervical cancer screening differs between individuals assigned female at birth who self-identify as men, transgender men, or FTM (i.e. binary) and those who self-identify as another transmasculine gender identity such as neither exclusively male nor female, agender, or genderqueer (i.e. non-binary).
Examines transmasculine individuals' and healthcare providers' perceptions of cervical cancer risk and screening among individuals on the transmasculine continuum.
Finds that several sexual and reproductive health indicators vary in relation to sexual identity and sexual behavior among Southern African American sexual minority women. Interventions that facilitate access to sexual and reproductive health services and are tailored to the unique needs of sexual orientation subgroups of sexual minority women are needed.
Examines the association between sexual orientation identity and HPV vaccination among U.S. women and girls.